Showing results (1-10 of 308) with videos related to
Sort By:
Pageof 31
Medicinal Research Reviews|November 5, 2003
The thioredoxin system--from science to clinicStephan Gromer, Sabine Urig, Katja BeckerSeminars in Cancer Biology|October 24, 2006
On the potential of thioredoxin reductase inhibitors for cancer therapySabine Urig, Katja BeckerJournal of Medicinal Chemistry|October 28, 2005
Synthesis of 5-nitro-2-furancarbohydrazides and their cis-diamminedichloroplatinum complexes as bitopic and irreversible human thioredoxin reductase inhibitorsRégis Millet, Sabine Urig, Judit Jacob, et al.Journal of Molecular Biology|May 22, 2007
The structure of human thioredoxin reductase 1 provides insights into C-terminal rearrangements during catalysisKarin Fritz-Wolf, Sabine Urig, Katja BeckerFEBS Letters|June 6, 2006
Truncated mutants of human thioredoxin reductase 1 do not exhibit glutathione reductase activitySabine Urig, Johanna Lieske, Karin Fritz-Wolf, et al.Free Radical Biology & Medicine|May 15, 2009
Differential genomic and proteomic profiling of glioblastoma cells exposed to terpyridineplatinum(II) complexesSasa Koncarevic, Sabine Urig, Klaus Steiner, et al.Biological Chemistry|October 17, 2007
Glutathione- and thioredoxin-related enzymes are modulated by sulfur-containing chemopreventive agentsYing Hu, Sabine Urig, Sasa Koncarevic, et al.Antimicrobial Agents and Chemotherapy|October 31, 2007
Interactions of methylene blue with human disulfide reductases and their orthologues from Plasmodium falciparumKathrin Buchholz, R Heiner Schirmer, Jana K Eubel, et al.The Journal of Biological Chemistry|January 10, 2002
Methylseleninate is a substrate rather than an inhibitor of mammalian thioredoxin reductase. Implications for the antitumor effects of seleniumStephan Gromer, Jurgen H GrossNucleic Acids Research|January 24, 2006
The Plasmodium selenoproteomeAlexey V Lobanov, Cesar Delgado, Stefan Rahlfs, et al.Pageof 31